Ami Jones, PA
Physician Assistant · Fremont, NENPI 1225097389
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 399 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $19.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1K
- Amgen$823
- Novartis$760
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$700
- Pfizer$510
- Abbott$485
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,884100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 57 | $1,438 |
| Amgen | 42 | $823 |
| Novartis | 54 | $760 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 57 | $700 |
| Pfizer | 36 | $510 |
| Abbott | 15 | $485 |
| AstraZeneca | 12 | $304 |
| Medtronic | 2 | $291 |
| Johnson & Johnson | 22 | $273 |
| Esperion Therapeutics, Inc. | 21 | $255 |
| Boston Scientific | 6 | $255 |
| Merck | 10 | $180 |
| Boehringer Ingelheim | 9 | $176 |
| Heartflow, Inc. | 2 | $166 |
| Actelion Pharmaceuticals US, Inc. | 7 | $160 |
| Abiomed | 1 | $148 |
| Bayer | 5 | $147 |
| Bridgebio Pharma, Inc. | 4 | $135 |
| Alnylam Pharmaceuticals Inc. | 4 | $77 |
| Edwards Lifesciences | 4 | $74 |
| Sanofi-aventis U.S. LLC | 4 | $70 |
| Impulse Dynamics (USA) Inc. | 3 | $63 |
| Scpharmaceuticals Inc. | 3 | $53 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $43 |
| Novo Nordisk | 2 | $38 |
| GSK | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $30 |
| Lexicon Pharmaceuticals, Inc. | 2 | $30 |
| Electromed, Inc. | 2 | $29 |
| Cardiva Medical, Inc. | 1 | $28 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
| United Therapeutics Corporation | 1 | $22 |
| Teleflex LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAMZYOS$373
- Repatha$230
- Micra$157
- WATCHMAN FLX$146
- FFRct$146
- COREVALVE EVOLUT R$135
- Kerendia$125
- WAINUA$115
How this compares
$7,884 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 248 | $193,601 |
| EntrestoSacubitril/Valsartan | 78 | $49,084 |
| XareltoRivaroxaban | 22 | $23,881 |
| JardianceEmpagliflozin | 18 | $23,684 |
| MultaqDronedarone Hcl | 15 | $16,493 |
| CorlanorIvabradine Hcl | 19 | $10,563 |
| FarxigaDapagliflozin Propanediol | 15 | $8,334 |
| Metoprolol Succinate | 369 | $4,667 |
| Potassium Chloride | 156 | $3,525 |
| Ezetimibe | 69 | $3,027 |
| EdarbiAzilsartan Medoxomil | 12 | $3,027 |
| Torsemide | 146 | $2,593 |
| Nebivolol Hcl | 54 | $2,546 |
| Amiodarone Hcl | 153 | $2,267 |
| Flecainide Acetate | 53 | $2,041 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $510 | $193,601248 claims |
| NovartisEntresto | $760 | $49,08478 claims |
| Johnson & JohnsonXarelto | $273 | $23,88122 claims |
| Boehringer IngelheimJardiance | $176 | $23,68418 claims |
| Sanofi-aventis U.S. LLCMultaq | $70 | $16,49315 claims |
| AmgenCorlanor | $823 | $10,56319 claims |
| AstraZenecaFarxiga | $304 | $8,33415 claims |
| Arbor Pharmaceuticals, Inc.Edarbi | $33 | $3,02712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Fremont
- Rita FowlerFremont$7K
- Ronald KmiecikFremont$6K
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Ronda FoleyElkhorn$64K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Joel JasaGrand Island$18K
- Christopher BeasleyOmaha$15K
- Courtney MaresLincoln$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.